Intralesional administration of biological response modifiers in the treatment of localized cancer of the prostate: a feasibility study

By Morales A.   Johnston B.   Emerson L.   Heaton J.W.P.  

Urology, Vol. 50, Iss. 4, 1997-10 ,pp. : 495-502

Elsevier

Access to resources Recommend Favorite

Chemotherapy in gastric cancer: a review and updated meta-analysis

By Janunger Karl-Gunnar  

European Journal of Surgery, Vol. 168, Iss. 11, 2002-01 ,pp. : 597-608

Informa Healthcare

Access to resources Recommend Favorite

Humoral immune response to p53 correlates with clinical course in colorectal cancer patients during adjuvant chemotherapy

By Lechpammer Mirna   Lukač Josip   Lechpammer Stanislav   Kovačević Dujo   Loda Massimo   Kusić Zvonko  

International Journal of Colorectal Disease, Vol. 19, Iss. 2, 2004-03 ,pp. : 114-120

Springer Publishing Company

Access to resources Recommend Favorite

Systemic Inflammatory Response in Gastric Cancer

By Yamashita Hiroharu  

World Journal of Surgery, Vol. 34, Iss. 10, 2010-10 ,pp. : 2399-2400

Springer Publishing Company

Access to resources Recommend Favorite

Pathological complete response of locally advanced gastric cancer after four courses of neoadjuvant chemotherapy with paclitaxel plus cisplatin: report of a case

By Watanabe Takafumi  

Surgery Today, Vol. 42, Iss. 10, 2012-10 ,pp. : 983-987

Springer Publishing Company

Access to resources Recommend Favorite